Synergistic effects of parthenolide and benznidazole on Trypanosoma cruzi

Phytomedicine

Volumn 18, Issue 1, 2010, Pages 36-39

  Pelizzaro Rocha, Karin Juliane ^a   Tiuman, Tatiana Shioji ^a   Izumi, Erika ^a   Ueda Nakamura, Tânia ^a   Filho, Benedito Prado Dias ^a   Nakamura, Celso Vataru ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Parthenolide; Synergism; Tanacetum vulgare; Trypanocidal activity; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE; PARTHENOLIDE;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ANTAGONISM; DRUG INHIBITION; DRUG ISOLATION; DRUG POTENTIATION; DRUG STRUCTURE; EPIMASTIGOTE; IC 50; IN VITRO STUDY; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; TANACETUM VULGARE; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

CELL CULTURE TECHNIQUES; DRUG SYNERGISM; HERB-DRUG INTERACTIONS; INHIBITORY CONCENTRATION 50; NITROIMIDAZOLES; PLANT LEAVES; SESQUITERPENES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

TANACETUM VULGARE; TRYPANOSOMA CRUZI;

EID: 78649782166     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2010.09.005     Document Type: Article

References (25)

1. Araújo M.S.S., Martins-Filho O.A., Pereira M.E.S., Brener Z.A. Combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease. J. Antimicrob. Chemother. 2000, 45:819-824.
2. Benaim G., Sanders J.M., Garcia-Marchán Y., Colina C., Lira R., Caldera A.R., Payares G., Sanoja C., Burgos J.M., Leon-Rossell A., Concepcion J.L., Schijman A.G., Levin M., Oldfield E., Urbina J.A. Amiodarone has Intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole. J. Med. Chem. 2006, 49:892-899.
3. Brener Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev. Inst. Med. Trop. S. Paulo 1962, 4:389-396.
4. Chou T.C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 2006, 58:621-681.
5. Hallander H.O., Dornbush K., Gezelius L., Jacobson K., Karlsson I. Synergism between aminoglycosides and cephalosporin with antipseudomonal activity: interaction index and killing curve method. Antimicrob. Agents Chemother. 1982, 22:743-752.
6. Izumi E., Morello L.G., Ueda-Nakamura T., Yamada-Ogatta S.F., Dias Filho B.P., Cortez D.A.G., Ferreira I.C.P., Morgado-Diaz J.A., Nakamura C.V. Trypanosoma cruzi: antiprotozoal activity of parthenolide obtained from Tanacetum parthenium (L.) Schultz Bip. (Asteraceae, Compositae) against epimastigote and amastigote forms. Exp. Parasitol. 2007, 118:324-330.
7. López-Muñoz R., Faúndez M., Klein S., Escanilla S., Torres G., Lee-Liu D., Ferreira J., Kemmerling U., Orellana M., Morello A., Ferreira A., Maya J.D. Trypanosoma cruzi: in vitro effect of aspirin with nifurtimox and benznidazole. Exp. Parasitol. 2010, 124:167-171.
8. Miglietta A., Bozzo F., Gabriel L., Bocca C. Microtubule-interfering activity of parthenolide. Chem. Biol. Interact. 2004, 149:165-173.
9. Murphy J.J., Heptinstall S., Mitchell J.R. Randomised doubleblind placebo-controlled trial of feverfew in migraine prevention. Lancet 1998, 2:189-192.
10. Onozato T., Nakamura C.V., Cortez D.A.G., Dias Filho B.P., Ueda-Nakamura T. Tanacetum vulgare: anti-herpes virus activity of crude extract and the purified compound parthenolide. Phytother. Res. 2009, 23:791-796.
11. Pfarrenrath V., Diener H.C., Fischer M., Friede M., Zepelin H.H. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis-a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia 2002, 22:523-532.
12. Rates S.M.K. Plants as source of drugs. Toxicon 2001, 39:603-613.
13. Salas C., Tapia R.A., Ciudad K., Armstrong V., Orellana M., Kemmerling U., Ferreira J., Maya J.D.M., Morello A. Trypanosoma cruzi: activities of lapachol and α- and β-lapachone derivatives against epimastigote and trypomastigote forms. Bioorg. Med. Chem. 2008, 16:668-674.
14. Shu Y. Recent natural products based drug development: a pharmaceutical industry perspective. J. Nat. Prod. 1998, 61:1053-1071.
15. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesh H., Boyd M.R. New colorimetric cytotoxicity assay for anti-cancer drug screening. J. Natl. Cancer Inst. 1990, 82:1107-1112.
16. Tiuman T.S., Ueda-Nakamura T., Cortez D.A.G., Dias Filho B.P., Morgado-Díaz J.A., De Souza W., Nakamura C.V. Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium. Antimicrob. Agents Chemother. 2005, 49:176-182.
17. Urbina J.A., Lazardi K., Aguirre T., Piras M.M., Piras R. Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 1988, 32:1237-1242.
18. Urbina J.A., Lazardi K., Marchan E., Visbal G., Aguirre T., Piras M.M., Piras R., Maldonado R.A., Payares G., Souza W. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob. Agents Chemother. 1993, 37:580-591.
19. 24(25) sterol methyl transferase inhibitors and their combinations with ketoconazole. Mol. Biochem. Parasitol. 1995, 73:199-210.
20. 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Chemotherapy 1996, 42:294-307.
21. Valdez R.H., Tonin L.T.D., Ueda-Nakamura T., Dias Filho B.P., Morgado-Diaz J.A., Sarragiotto M.H., Nakamura C.V. Biological activity of 1,2,3,4-tetrahydro-β-carboline-3-carboxamides against Trypanosoma cruzi. Acta Trop. 2009, 110:7-14.
22. Viotti R., Vigliano C., Armenti H., Segura E. Treatment of chronic Chaga's disease with benznidazole: clinical and serological evolution of patients with long term follow-up. Am. Heart J. 1994, 127:151-162.
23. Wagner H., Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 2009, 16:97-110.
24. WHO/TDR - World Health Organization, 2006. Report of the Scientific Working Group on Chagas Disease. Buenos Aires, Geneva, p. 7.
25. Yoshida N. Molecular mechanisms of Trypanosoma cruzi infection by oral route. Mem. Inst. Oswaldo Cruz 2009, 104:101-107.